DSM-V critique: The Power Of NO Versus Psychiatry's Massive Overtreatment

[Guest guest]

" It is clear that the beneficiaries of APA's

expansionist DSM-V revisions are those with vested financial stakes in

maintaining high volume sales of clinically dubious, but highly

profitable drugs. "

 

 

 

The Power Of NO Versus Psychiatry's Massive Overtreatment

 

 

 

New York Times columnist, David Leonhardt, applauds the new

Medicare policy inaugurating comparative risk/ benefit analyses of

medical treatments as a means of reducing healthcare costs--and also to

reduce risks of serious side-effects from unnecessary treatments. He

notes that " unnecessary care causes a lot of pain and even

death. " Dr Allen Frances, Prof. Emeritus, former chairman of

psychiatry, Duke University and the DSM-IV Task Force warns that the

American Psychiatric Association's effort to expand its reach by

pathologizing those it deems " at risk " could lead to a public

health catastrophe and no field trial could possibly justify its

inclusion as an official diagnosis. It is clear that the beneficiaries of

APA's expansionist DSM-V revisions are those with vested financial stakes

in maintaining high volume sales of clinically dubious, but highly

profitable drugs.

Vera Hassner Sharav, AHRP

 

 

 

Sheri Nakken, R.N., MA, Hahnemannian

Homeopath

Vaccination Information & Choice Network, Washington State, USA

Vaccines -

 

http://vaccinationdangers.wordpress.com/ Homeopathy

 

http://homeopathycures.wordpress.com

Vaccine Dangers, Childhood Disease Classes & Homeopathy

Online/email courses - next classes start March 24, March 31, & April

1